Administration Measures News Today

Dailymirror.lk – Sri Lanka 24 Hours Online Breaking News : News, Politics, Video, Finance, Business, Sports, Entertainment, Travel, sri lanka news,sri lanka latest news, latest breaking news, latest political news, covid-19 news,covid-19 news sri lanka, Sri Lanka Coronavirus updates, sl news, sl covid-19 news, SL breaking news, daily news, breaking news in sri lanka

We round up the most recent developments in the exciting Chinese beauty market, featuring news updates from Coty, Yatsen, Fancl, and more.

China has announced a new set of measures to tighten regulation of beauty e-commerce platforms and merchants, protect the interests of consumers, and enhance safety and quality of products sold online.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________ ... | May 3, 2023

Lufax Holding Ltd Supplemental and Updated Disclosures Lufax Holding Ltd has published a listing document with the Stock Exchange of Hong Kong Limited ,... | April 11, 2023

This is a review of China's key developments during H2 2022 in antitrust, civil law, corporate, data and cybersecurity, foreign investment and medical treatment including China’s Supreme Court proposed revisions to civil litigation rules under the Anti Monopoly Law.

This article covers regulatory updates made between August and December 2022 in China, Hong Kong S.A.R., South Korea, Thailand and the Phillipines. Many focus on increased ingredient restrictions; most notably a ban on CBD products in Hong Kong S.A.R.

This article covers regulatory updates made between August and December 2022 in China, Hong Kong S.A.R., South Korea, Thailand and the Phillipines. Many focus on increased ingredient restrictions; most notably a ban on CBD products in Hong Kong S.A.R.

Investors are eyeing opportunities in China. One of the sectors of interest is the biotech sector.

A prime opportunity for China’s domestic drug development industry to capitalise on the growing need for new therapeutics.